24 - 27 January 2022

Dubai World Trade Centre

5 January - 28 February

Sustainable Solutions for Safe Childbirth - Remote Mobile Fetal Monitor ‘iCTG’


Melody International


Tuesday 25th January | 15:00

Transformation Zone | S2.D70

Product description

iCTG Mobile Fetal Monitor

The Melody iCTG mobile fetal monitor – the smallest approved fetal monitor on the market – uses this principle of Doppler-based fetal monitoring with ‘real time adaptive autocorrelation’ to monitor the pregnancy.

Melody iCTG is composed of two small devices worn by the expectant mother. One device measures the fetal heart rate, and the other measures uterine contractions.


Company bio

Abdul Latif Jameel Health introduces: Melody International

In 1974, Prof. Kazuhiro Hara and Prof. Yasuhito Takeuchi (today advisors to Melody Intl.) made a disruptive breakthrough on Doppler-based fetal monitoring systems with their ‘real time adaptive autocorrelation’ method – now the de-facto standard in this field implemented in virtually all clinical fetal monitoring. Melody International Ltd. developed iCTG, the smallest fetal monitor in the world that uses the principle of real time autocorrelation. Despite its size, iCTG has the same functionality as conventional hospital-based machines and is approved by Japan’s PMDA. Until now, such technology was only available only inside the hospital, but iCTG’s portability allows it to be used at any location, even by non-medical personnel. Together, Abdul Latif Jameel Health and Melody Intl. aim to reduce the risk of perinatal emergencies or deaths across the region.


Dr. Akram Bouchenaki
CEO Abdul Latif Jameel Health

Akram Bouchenaki is Chief Executive Officer of Abdul Latif Jameel Health, Abdul Latif Jameel’s health care business, focusing on accelerating access to modern medical care while addressing unmet medical needs in developing markets around the World. Abdul Latif Jameel Health is part of Abdul Latif Jameel, a collective of independent international, family-owned and diversified businesses, founded in 1945 by the late Abdul Latif Jameel.

Dr. Bouchenaki joins Abdul Latif Jameel Health after 25 years of operational and strategic roles in the pharmaceutical and healthcare sectors, including global leadership roles in ‘big-pharma’ corporates as well as in top California-based biotech, where he was an executive director for Africa covering the largest markets on the continent.

Akram has extensive knowledge and experience of both generics and branded medicines in established as well as key emerging markets across the world. These include Africa’s most significant markets, Brazil, and Mexico, having co-founded a fast-growing start-up to commercialize medicines in Latin America.

Akram holds a Doctorate in Pharmacy from Université de Paris V, France. He has lived and worked in 9 different countries across 5 continents. He speaks French, Spanish, Arabic, Portuguese and English.

Ms. Yuko OGATA
Founder & CEO, Melody Intl.

This is Yhuko’s second start-up. She previously successfully commercialized Japan’s first EMR for Obstetricians and Gynecologists. Using her experience with digital networks / medical ICT, she now aims to establish and commercialize perinatal telemedicine platform for expectant mother’s safe and secure deliveries around the world. Yhuko was awarded Nikkei woman of the year in 2021 one of the notable awards for entrepreneurs in Japan. Previously, she also received Japan Venture Awards in 2009.

CIO, Melody Intl.

A graduate of Hosei University Department of Philosophy, Keiji worked as a sales representative for family owned printing business, but it went out of business right after he joined management team. As a manager, his first task was to hold creditors meeting, take care of debts, and to transfer employee and facilities to another capital. Becoming aware of the importance of management skills, he obtained MBA from Kagawa University. Using his experience as an ISO9001 quality control manager, he now manages quality check of Melody International’s medical device.